Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Cha, Hyuk-Jin  [Clear All Filters]
2024
Kim K-T, Kim S-M, Cha H-J. Crosstalk between Signaling Pathways and Energy Metabolism in Pluripotency. Int J Stem Cells. 2024.
Kim J, Kwon E-J, Kim Y-J, Kim D, Shin Y-Z, Gil D, Kim J-H, Shin HDoo, Kim LHyo, Lee M-O, et al. Epigenetic repression of CHCHD2 enhances survival from single cell dissociation through attenuated Rho A kinase activity. Cell Mol Life Sci. 2024;81(1):38.
2023
Park J-C, Park MJeong, Lee S-Y, Kim D, Kim K-T, Jang H-K, Cha H-J. Gene editing with 'pencil' rather than 'scissors' in human pluripotent stem cells. Stem Cell Res Ther. 2023;14(1):164.
Park J-C, Kim Y-J, Han JHee, Kim D, Park MJeong, Kim J, Jang H-K, Bae S, Cha H-J. MutSα and MutSβ as size-dependent cellular determinants for prime editing in human embryonic stem cells. Mol Ther Nucleic Acids. 2023;32:914-922.
Kim J, Kim S, Lee S-Y, Jo B-K, Oh J-Y, Kwon E-J, Kim K-T, Adpaikar AAshok, Kim E-J, Jung H-S, et al. Partial in vivo reprogramming enables injury-free intestinal regeneration via autonomous induction. Sci Adv. 2023;9(47):eadi8454.
Jeong H-C, Go Y-H, Shin J-G, Kim Y-J, Cho M-G, Gwon D, Cheong HSub, Lee H, Lee J-H, Jang C-Y, et al. TPX2 Amplification-Driven Aberrant Mitosis in Culture Adapted Human Embryonic Stem Cells with gain of 20q11.21. Stem Cell Rev Rep. 2023.
Kim Y-J, Go Y-H, Jeong H-C, Kwon E-J, Kim S-M, Cheong HSub, Kim W, Shin HDoo, Lee H, Cha H-J. TPX2 prompts mitotic survival via the induction of BCL2L1 through YAP1 protein stabilization in human embryonic stem cells. Exp Mol Med. 2023.
2022
Kim S-M, Kwon E-J, Kim Y-J, Go Y-H, Oh J-Y, Park S, Do JTae, Kim K-T, Cha H-J. Dichotomous role of Shp2 for naïve and primed pluripotency maintenance in embryonic stem cells. Stem Cell Res Ther. 2022;13(1):329.
Kim SYeon, Lee S, Woo H, Han J, Ko YJun, Shim Y, Park S, Jang SSong, Lim BChan, Ko JMin, et al. The Korean undiagnosed diseases program phase I: expansion of the nationwide network and the development of long-term infrastructure. Orphanet J Rare Dis. 2022;17(1):372.
Koo K-M, Go Y-H, Kim S-M, Kim C-D, Do JTae, Kim T-H, Cha H-J. Label-free and non-destructive identification of naïve and primed embryonic stem cells based on differences in cellular metabolism. Biomaterials. 2022;293:121939.
Park J-C, Kim J, Jang H-K, Lee S-Y, Kim K-T, Kwon E-J, Park S, Lee HSik, Choi H, Park S-Y, et al. Multiple isogenic GNE-myopathy modeling with mutation specific phenotypes from human pluripotent stem cells by base editors. Biomaterials. 2022;282:121419.
2020
Kwon O-S, Lee H, Kong H-J, Kwon E-J, Park JEun, Lee W, Kang S, Kim M, Kim W, Cha H-J. Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer. Oncogene. 2020.
Kim K-T, Park J-C, Jang H-K, Lee H, Park S, Kim J, Kwon O-S, Go Y-H, Jin Y, Kim W, et al. Safe scarless cassette-free selection of genome-edited human pluripotent stem cells using temporary drug resistance. Biomaterials. 2020;262:120295.
Kwon O-S, Kwon E-J, Kong H-J, Choi J-Y, Kim Y-J, Lee E-W, Kim W, Lee H, Cha H-J. Systematic identification of a nuclear receptor-enriched predictive signature for erastin-induced ferroptosis. Redox Biol. 2020;37:101719.
2019
Go Y-H, Lim C, Jeong H-C, Kwon O-S, Chung S, Lee H, Kim W, Suh Y-G, Son WSung, Lee M-O, et al. Structure-Activity Relationship Analysis of YM155 for Inducing Selective Cell Death of Human Pluripotent Stem Cells. Front Chem. 2019;7:298.
2015
Yea C-H, Jeong H-C, Moon S-H, Lee M-O, Kim K-J, Choi J-W, Cha H-J. In situ label-free quantification of human pluripotent stem cells with electrochemical potential. Biomaterials. 2015;75:250-259.
Wang S, Lee J-S, Hyun J, Kim J, Kim SU, Cha H-J, Jung Y. Tumor necrosis factor-inducible gene 6 promotes liver regeneration in mice with acute liver injury. Stem Cell Res Ther. 2015;6(1):20.